Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 39.20
+0.96 (2.51%)
Feb 13, 2026, 4:08 PM HKT
Everest Medicines Employees
Everest Medicines had 722 employees as of June 30, 2025.
Employees
722
Change
n/a
Growth
n/a
Revenue / Employee
1.29M HKD
Profits / Employee
-999.79K HKD
Market Cap
13.51B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 722 | - | - |
| Dec 31, 2024 | 665 | 233 | 53.94% |
| Dec 31, 2023 | 432 | 67 | 18.36% |
| Jun 30, 2023 | 395 | - | - |
| Dec 31, 2022 | 365 | -40 | -9.88% |
| Dec 31, 2021 | 405 | 256 | 171.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,156 |
| Zai Lab | 1,869 |
| Keymed Biosciences | 1,469 |
| Ascentage Pharma Group International | 605 |
| Lepu Biopharma | 546 |
| Alphamab Oncology | 484 |
| Abbisko Cayman | 226 |
| HBM Holdings | 210 |
Everest Medicines News
- 3 days ago - Everest Medicines Advances With Major Licensing Deal, New Drug Application Approval - Benzinga
- 11 months ago - AI-powered Cancer Vaccine In The Works - Benzinga
- 1 year ago - Kezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update - Benzinga